胸部CT扫描规范化专家共识

2020-02-28 中国医疗设备.2020,35(2):185-189.

胸部CT 扫描是临床上检查胸部疾病的主要手段之一。据统计,国内医疗机构的CT 设备供应商有很多,不同厂家所生产的CT 设备在成像技术、成像参数及图像后处理技术方面也不尽相同;同时,不同的医疗机构的工作

中文标题:

胸部CT扫描规范化专家共识

英文标题:

胸部CT扫描规范化专家共识

发布机构:

发布日期:

2020-02-28

简要介绍:

胸部CT 扫描是临床上检查胸部疾病的主要手段之一。据统计,国内医疗机构的CT 设备供应商有很多,不同厂家所生产的CT 设备在成像技术、成像参数及图像后处理技术方面也不尽相同;同时,不同的医疗机构的工作人员也存在临床技能、诊断水平良莠不齐的情况。对于胸部CT扫描而言,虽然设备厂家均提供了参考性的操作指南,但是实际检查中由于各种具体问题,会出现很多操作不规范的地方,即便是同一型号的CT 设备,各个医疗机构之间也存在扫描差异。在胸部CT 扫描方面,尚缺乏标准化的CT 扫描、图像后处理和质量控制的方案,尤其体现在社会各界更为关注CT检查的辐射剂量和辐射安全问题。因此,在如何规范操作完成胸部CT 扫描、降低辐射剂量方面, 亟需达成专家共识。基于上述多种原因,在多年来迅速积累了一定的使用经验和循证医学证据后,有必要推出胸部CT 扫描临床应用专家共识。

相关资料下载:
[AttachmentFileName(sort=1, fileName=)] GetToolGuiderByIdResponse(projectId=1, id=d31aa1c0018e38fe, title=胸部CT扫描规范化专家共识, enTitle=胸部CT扫描规范化专家共识, guiderFrom=中国医疗设备.2020,35(2):185-189., authorId=0, author=, summary=胸部CT 扫描是临床上检查胸部疾病的主要手段之一。据统计,国内医疗机构的CT 设备供应商有很多,不同厂家所生产的CT 设备在成像技术、成像参数及图像后处理技术方面也不尽相同;同时,不同的医疗机构的工作, cover=https://medsci-open-files.oss-cn-shanghai.aliyuncs.com/GAD_1583648110000.jpg, journalId=0, articlesId=null, associationId=0, associationName=, associationIntro=, copyright=0, guiderPublishedTime=Fri Feb 28 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>胸部CT 扫描是临床上检查胸部疾病的主要手段之一。据统计,国内医疗机构的CT 设备供应商有很多,不同厂家所生产的CT 设备在成像技术、成像参数及图像后处理技术方面也不尽相同;同时,不同的医疗机构的工作人员也存在临床技能、诊断水平良莠不齐的情况。对于胸部CT扫描而言,虽然设备厂家均提供了参考性的操作指南,但是实际检查中由于各种具体问题,会出现很多操作不规范的地方,即便是同一型号的CT 设备,各个医疗机构之间也存在扫描差异。在胸部CT 扫描方面,尚缺乏标准化的CT 扫描、图像后处理和质量控制的方案,尤其体现在社会各界更为关注CT检查的辐射剂量和辐射安全问题。因此,在如何规范操作完成胸部CT 扫描、降低辐射剂量方面, 亟需达成专家共识。基于上述多种原因,在多年来迅速积累了一定的使用经验和循证医学证据后,有必要推出胸部CT 扫描临床应用专家共识。</p> </div> </div> </div>, tagList=[TagDto(tagId=8857, tagName=胸部CT)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=40, categoryName=影像放射, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=8857, guiderKeyword=胸部CT, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=共识, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3806, appHits=207, showAppHits=14, pcHits=1596, showPcHits=3588, likes=3, shares=4, comments=15, approvalStatus=1, publishedTime=Tue Mar 10 17:41:36 CST 2020, publishedTimeString=2020-02-28, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=8, createdBy=null, createdName=qiushida2, createdTime=Sun Mar 08 14:15:30 CST 2020, updatedBy=1, updatedName=小M, updatedTime=Sat Jan 06 21:13:50 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=)])
下载请点击:
评论区 (13)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1070923, encodeId=c14210e0923c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Nov 16 22:28:11 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057722, encodeId=09ad105e7225e, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3c1751447, createdName=ms2855462108604109, createdTime=Mon Oct 04 23:56:40 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962468, encodeId=954e962468f4, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:30 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962467, encodeId=d49c96246e3b, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:14 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926330, encodeId=fb40926330b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/9f760f77b8db4a01937ed9ed3ebc52a6/c60f3c740de34bc9bd3d7f9148b2bfd4.jpg, createdBy=604c5461047, createdName=幻影, createdTime=Mon Feb 22 11:47:36 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-11-16 genglihui01

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1070923, encodeId=c14210e0923c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Nov 16 22:28:11 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057722, encodeId=09ad105e7225e, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3c1751447, createdName=ms2855462108604109, createdTime=Mon Oct 04 23:56:40 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962468, encodeId=954e962468f4, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:30 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962467, encodeId=d49c96246e3b, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:14 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926330, encodeId=fb40926330b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/9f760f77b8db4a01937ed9ed3ebc52a6/c60f3c740de34bc9bd3d7f9148b2bfd4.jpg, createdBy=604c5461047, createdName=幻影, createdTime=Mon Feb 22 11:47:36 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-10-04 ms2855462108604109

    好好学习一下

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1070923, encodeId=c14210e0923c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Nov 16 22:28:11 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057722, encodeId=09ad105e7225e, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3c1751447, createdName=ms2855462108604109, createdTime=Mon Oct 04 23:56:40 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962468, encodeId=954e962468f4, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:30 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962467, encodeId=d49c96246e3b, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:14 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926330, encodeId=fb40926330b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/9f760f77b8db4a01937ed9ed3ebc52a6/c60f3c740de34bc9bd3d7f9148b2bfd4.jpg, createdBy=604c5461047, createdName=幻影, createdTime=Mon Feb 22 11:47:36 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-05-03 ms8622563200651261

    好资料

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1070923, encodeId=c14210e0923c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Nov 16 22:28:11 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057722, encodeId=09ad105e7225e, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3c1751447, createdName=ms2855462108604109, createdTime=Mon Oct 04 23:56:40 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962468, encodeId=954e962468f4, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:30 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962467, encodeId=d49c96246e3b, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:14 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926330, encodeId=fb40926330b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/9f760f77b8db4a01937ed9ed3ebc52a6/c60f3c740de34bc9bd3d7f9148b2bfd4.jpg, createdBy=604c5461047, createdName=幻影, createdTime=Mon Feb 22 11:47:36 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-05-03 ms8622563200651261

    学习一下!

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1070923, encodeId=c14210e0923c5, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1d8f1319483, createdName=genglihui01, createdTime=Tue Nov 16 22:28:11 CST 2021, time=2021-11-16, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1057722, encodeId=09ad105e7225e, content=好好学习一下, beContent=null, objectType=guider, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=cc3c1751447, createdName=ms2855462108604109, createdTime=Mon Oct 04 23:56:40 CST 2021, time=2021-10-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962468, encodeId=954e962468f4, content=好资料, beContent=null, objectType=guider, channel=null, level=null, likeNumber=40, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:30 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962467, encodeId=d49c96246e3b, content=学习一下!, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210503/eb6834ba8c7647ca8956cd5e6d91703d/fe147f544b9647c48bb749c362894859.jpg, createdBy=b2971850540, createdName=ms8622563200651261, createdTime=Mon May 03 16:54:14 CST 2021, time=2021-05-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=926330, encodeId=fb40926330b5, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210222/9f760f77b8db4a01937ed9ed3ebc52a6/c60f3c740de34bc9bd3d7f9148b2bfd4.jpg, createdBy=604c5461047, createdName=幻影, createdTime=Mon Feb 22 11:47:36 CST 2021, time=2021-02-22, status=1, ipAttribution=)]
    2021-02-22 幻影

    学习

    0

拓展阅读

胸部CT肺结节数据标注与质量控制专家共识(2018)

中华医学会放射学分会(CSR,chinese society of radiology) 心胸学组 · 2019-01-30

2021 NICE 医疗技术创新简报:人工智能用于胸部CT图像分析【MIB243】

英国国家卫生与临床优化研究所(NICE,National Institute for Health and Clinical Excellence) · 2021-01-05